Programmed death-ligand 1 expression influenced by tissue sample size. Scoring based on tissue microarrays’ and cross-validation with resections, in patients with, stage I–III, non-small cell lung carcinoma of the European Thoracic Oncology Platform Lungscape cohort
Erik Thunnissen*, Keith M. Kerr, Urania Dafni, Lukas Bubendorf, Stephen P. Finn, Alex Soltermann, Wojciech Biernat, Richard Cheney, Erik Verbeken, Arne Warth, Antonio Marchetti, Ernst Jan M. Speel, Saraswati Pokharel, Anne Marie Quinn, Kim Monkhorst, Atilio Navarro, Line Bille Madsen, Zoi Tsourti, Thomas Geiger, Roswitha KammlerSolange Peters, Rolf A. Stahel, Rafael Rosell, Fiona Blackhall, Miguel Angel Molina, Walter Weder, Stephen Finn, Anita Hiltbrunner, Nesa Marti, Varvara Polydoropoulou, Panagiota Zygoura, Marianne Nicolson, David A.J. Stevenson, William Mathieson, Egbert Smit, Teodora Radonic, Undine Rulle, Alessandra Curioni, Steven G. Gray, Kathy Gately, Martin Barr, Peter Meldgaard, Line B. Madsen, Spasenija Savic, Didier Lardinois, Kristiaan Nackaerts, Christophe Dooms, Els Wauters, Sara Van Der Borght, Ania Wrona, for the European Thoracic Oncology Platform Lungscape Consortium
*Corresponding author for this work
Research output: Contribution to journal › Article › Research › peer-review
28Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Programmed death-ligand 1 expression influenced by tissue sample size. Scoring based on tissue microarrays’ and cross-validation with resections, in patients with, stage I–III, non-small cell lung carcinoma of the European Thoracic Oncology Platform Lungscape cohort'. Together they form a unique fingerprint.